t
On 4 November 2026, Barclays PLC announced the completion of its HY 2026 share buy-back programme, having repurchased 213,040,129 ordinary shares through Citigroup Global Markets Limited for a total consideration of approximately £1,000 million. Following the cancellation of the repurchased shares, Barclays' total issued share capital and voting rights consist of 13,316,503,028 ordinary shares. The company also announced that its Q3 2026 share buy-back programme to purchase ordinary shares for up to a maximum consideration of £500 million commenced on 4 November 2026.
| Date | 4 Nov 2026 |
| Time | 07:15:01 |
| Category | Capital structure |
| ID | 6820B |
4 November 2026
Barclays PLC
Transaction in own shares, completion of HY 2026 buy-back and commencement of Q3 2026 buy-back
Completion of HY 2026 buy-back
Barclays PLC (the “Company”) announces that it has purchased for cancellation the following number of its ordinary shares of 25 pence each on the London Stock Exchange from Citigroup Global Markets Limited (“Citi”) as part of its buy-back announced on 29 July 2026:
|
Date of purchase: |
Number of ordinary shares |
Highest price paid per share: |
Lowest price paid per share: |
Volume weighted average price paid per share: |
|
02 November 2026 |
4,166,932 |
426.2000p |
413.9500p |
419.9733p |
|
03 November 2026 |
3,123,216 |
429.1500p |
418.0000p |
421.7155p |
The Company intends to cancel all of the purchased ordinary shares.
Following the cancellation of the repurchased shares, the Company’s issued share capital will consist of 13,316,503,028 ordinary shares. Therefore, the total voting rights in the Company will be 13,316,503,028.
There are no ordinary shares held in Treasury.
The above figure (13,316,503,028) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by Citi on behalf of the Company can be found at:
http://www.rns-pdf.londonstockexchange.com/rns/6820B_1-2026-11-3.pdf
The Company announces that, following the purchase of these shares, the share buy-back programme announced on 29 July 2026 has completed. Since the commencement of the buy-back, the Company has repurchased for cancellation 213,040,129 ordinary shares in aggregate at a volume weighted average price of 469.3951p per ordinary share for a total consideration of approximately £1,000 million.
Commencement of Q3 2026 buy-back
The Company announces that, further to the completion of the share buy-back programme announced on 29 July 2026, the share buy-back programme announced on 23 October 2026 to purchase ordinary shares for up to a maximum consideration of £500m will commence on 4 November 2026. The maximum number of ordinary shares which may be purchased under such buy-back is 1,165,758,040.
- ENDS -
For further information, please contact:
|
Investor Relations |
Media Relations |
|
Mathias Peters +44 (0) 20 3134 3033 |
Susie Guo +44 (0) 20 3555 2560 |
About Barclays
Our vision is to be the UK-centred leader in global finance. We are a diversified bank with comprehensive UK consumer, corporate and wealth and private banking franchises, a leading investment bank and a strong, specialist US consumer bank. Through these five divisions, we are working together for a better financial future for our customers, clients and communities.
For further information about Barclays, please visit our website home.barclays.